BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jung JY, Pashia ME, Nishimoto SY, Faddis BT, Chole RA. A possible role for nitric oxide in osteoclastogenesis associated with cholesteatoma. Otol Neurotol 2004;25:661-8. [PMID: 15353992 DOI: 10.1097/00129492-200409000-00003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Barbara M, Covelli E, Monini S, Bandiera G, Filippi C, Margani V, Volpini L, Salerno G, Romano A, Bozzao A. Early non-EPI DW-MRI after cholesteatoma surgery. Ear Nose Throat J 2021;:1455613211042946. [PMID: 34846196 DOI: 10.1177/01455613211042946] [Reference Citation Analysis]
2 Solanki B, Sharma S. Cholesteatoma Versus Granulations: Changing Incidence Trends and Association with Age and Complications. Indian J Otolaryngol Head Neck Surg 2020;72:208-13. [PMID: 32551279 DOI: 10.1007/s12070-019-01765-0] [Reference Citation Analysis]
3 Semaan MT, Megerian CA. The pathophysiology of cholesteatoma. Otolaryngol Clin North Am 2006;39:1143-59. [PMID: 17097438 DOI: 10.1016/j.otc.2006.08.003] [Cited by in Crossref: 82] [Cited by in F6Publishing: 58] [Article Influence: 5.5] [Reference Citation Analysis]
4 Baysal E, Aksoy N, Kara F, Taysi S, Taşkın A, Bilinç H, Cevik C, Celenk F, Kanlıkama M. Oxidative stress in chronic otitis media. Eur Arch Otorhinolaryngol 2013;270:1203-8. [PMID: 22711004 DOI: 10.1007/s00405-012-2070-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
5 Imai R, Sato T, Iwamoto Y, Hanada Y, Terao M, Ohta Y, Osaki Y, Imai T, Morihana T, Okazaki S, Oshima K, Okuzaki D, Katayama I, Inohara H. Osteoclasts Modulate Bone Erosion in Cholesteatoma via RANKL Signaling. J Assoc Res Otolaryngol 2019;20:449-59. [PMID: 31254133 DOI: 10.1007/s10162-019-00727-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
6 Samy RN, Earl BR, Lipschitz N, Schweinzger I, Currier M, Cripe T. Engineered oncolytic virus for the treatment of cholesteatoma: A pilot in vivo study. Laryngoscope Investig Otolaryngol 2019;4:532-42. [PMID: 31637298 DOI: 10.1002/lio2.307] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Turan M, Ucler R, Aslan M, Kalkan F, Taskın A, Garca MF, Cankaya H. Serum paraoxonase and arylesterase activities in patients with chronic otitis media. Redox Rep 2015;20:241-5. [PMID: 25968808 DOI: 10.1179/1351000215Y.0000000012] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Xie S, Wang X, Ren J, Liu W. The role of bone resorption in the etiopathogenesis of acquired middle ear cholesteatoma. Eur Arch Otorhinolaryngol 2017;274:2071-8. [DOI: 10.1007/s00405-016-4422-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
9 Hamed MA, Nakata S, Sayed RH, Ueda H, Badawy BS, Nishimura Y, Kojima T, Iwata N, Ahmed AR, Dahy K, Kondo N, Suzuki K. Pathogenesis and Bone Resorption in Acquired Cholesteatoma: Current Knowledge and Future Prospectives. Clin Exp Otorhinolaryngol 2016;9:298-308. [PMID: 27440129 DOI: 10.21053/ceo.2015.01662] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]